Daniel Vincent O'Hara

10PUBLICATIONS
17CO-AUTHORS
Aboriginal and Torres Strait Islander medicine and treatmentsMolecular targetsBehavioural epidemiologyBiologically active moleculesPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 02, 2026
Barriers and Facilitators for Sodium-Glucose Cotransporter-2 Inhibitor Uptake and Implementation in Australia - Perspectives From Clinicians and Patients: An Interview Study.

|Apr 08, 2025
A review of the safety of sodium-glucose co-transporter-2 inhibitors.

Daniel Vincent O'Hara, Meg J Jardine

|Nov 28, 2024
Rate of decline in kidney function with age: a systematic review.

Michelle Guppy, Elizabeth Taruna Thomas, Paul Glasziou

|Oct 22, 2024
Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial.

Daniel Vincent O'Hara, Abhinav Bassi, Arlen Wilcox

|Apr 26, 2024
Applications of SGLT2 inhibitors beyond glycaemic control.

Daniel V O'Hara, Carolyn S P Lam, John J V McMurray

|Feb 08, 2022
SGLT2 inhibitors may prevent diabetes.

Daniel V O'Hara, Meg J Jardine

Pageof 2

Frequent Collaborators

3 joint publications

Meg J Jardine

1 joint publications

Sunil V Badve

1 joint publications

Min Jun

1 joint publications

Vlado Perkovic